LILRB3 and acute myeloid leukemia: Considering that we have demonstrated that miR-103a-2-5p mimics could reduce LILRB3 mRNA and protein levels and miR-103a-2-5p is downregulated in AML patients and cell lines, it is necessary to evaluate whether enhanced miR-103a-2-5p expression would affect the biological activity of AML cells by reducing the expression of LILRB3.